NetworkNewsBreaks

FridayDec 27, 2024 3:22 pm

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Collaborates to Bring AI-Powered Robotics to Forefront of Hospitality Operations

A recent partnership between Nightfood Holdings (OTCQB: NGTF) subsidiary, Future Hospitality Ventures Holdings (“FHV”) Inc., and Bear Robotics is a standout example of the impact artificial intelligence (“AI”) is making in the hospitality industry. “This collaboration aims to bring AI-powered robotics to the forefront of hospitality operations, blending innovative technology with guest-centered service,” reads a recent article. “FHV is committed to advancing innovation within the hospitality sector,” said FHV president Sonny Wang, who noted that the collaboration marks a major milestone in the company’s mission to redefine the U.S. hospitality industry, beginning in Greater Los Angeles and with plans to expand nationwide.…

Continue Reading

FridayDec 27, 2024 2:15 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Integrates AI Characters into Social Media

Meta (NASDAQ: META) is set to enhance its social media platforms, Instagram and Facebook, by integrating artificial intelligence (“AI”) characters. These AI characters will generate and share content alongside existing user accounts. Connor Hayes, Meta’s vice president of product for generative AI, shared this development with the Financial Times. Meta’s financial metrics provide insight into its market position. The company’s price-to-earnings (“P/E”) ratio is 26.91, showing the price investors are willing to pay for each dollar of earnings. This suggests that investors have confidence in Meta’s future earnings potential, which could be bolstered by the integration of AI characters. The…

Continue Reading

FridayDec 27, 2024 1:39 pm

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Opportunities Beyond ‘Year of Significant Progress’

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, was featured in a recent article that discussed the company’s year-end investor webcast, where it provided stakeholders with a comprehensive overview of 2024 milestones and strategic initiatives for 2025. The webcast also highlighted financial developments, including the securing of a $50 million At-The-Market (“ATM”) offering and ongoing strategic efforts to raise additional funds to support clinical trial development and long-term growth. “2024 has been a year of significant progress for Annovis Bio, and we are excited about the opportunities ahead,” Dr. Maria Maccecchini, founder, president…

Continue Reading

FridayDec 27, 2024 1:30 pm

NetworkNewsBreaks – Upstream Focusing on Next-Level Trading Experience to Empower Today’s Investors

Upstream published a blog today that discussed how it is differentiating itself from traditional platforms and offering key benefits in the future of stock trading. “While conventional exchanges often rely on brokers, limited funding methods, and traditional trading hours, Upstream offers direct access to a peer-to-peer market with real-time trading, flexible funding methods including PayPal and USDC, and 20/7 trading availability,” the blog reads. ““Leveraging blockchain technology with investor-focused features, Upstream aims to usher in the next evolution of trading.” To view the full blog, visit https://nnw.fm/Lf0WP About Upstream Upstream, a MERJ Exchange market (https://merj.exchange), is a global securities trading…

Continue Reading

FridayDec 27, 2024 12:14 pm

NetworkNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S., today reviewed highlights and announced future plans in a letter to shareholders. In addition to outlining multiple accomplishments from 2024, the company indicated that it intends “to expand into ‘consumer packaged goods’ utilizing our rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian, Santa Marta Gold, African Ebony, Jamaican, Thai (ThaiSticks) and Andalusian Nepalese (remember Temple Balls - Hash),” the letter reads. “As your president and CEO, I’m so very grateful for your support and patience as our team at WEED moves…

Continue Reading

ThursdayDec 26, 2024 3:30 pm

NetworkNewsBreaks – Why Adageis Is ‘One to Watch’

Adageis focuses on leveraging advanced technology to meet the growing demand for value-based care and quality incentives in the healthcare sector. “With a commitment to innovation and practical solutions, Adageis empowers clinics, healthcare centers, and care networks to implement its ProActive Care Platform without the need for expensive platform changes or extensive staff training,” reads a recent article. “This approach reduces barriers to adoption and helps healthcare organizations maximize their potential in an increasingly complex industry landscape.” To view the full article, visit https://nnw.fm/C0WJd About Adageis Adageis is a healthcare technology innovator focused on addressing inefficiencies in care delivery through AI…

Continue Reading

ThursdayDec 26, 2024 3:29 pm

NetworkNewsBreaks – DealFlow Events’ Upcoming Conference to Showcase Insights, Foster Connections in the Microcap Community

DealFlow Events has announced further details for its highly anticipated Microcap Conference, slated to take place at the iconic Borgata Hotel Casino & Spa in Atlantic City from Jan. 28-30, 2025. The event serves as a premier platform for growth companies and will bring together more than 100 presenters and over 500 institutional, accredited and retail investors for three days of company presentations, one-on-one meetings, and unparalleled networking opportunities. Presenting companies span a variety of sectors, including financial services, cybersecurity, healthcare, biotechnology and clean energy. The agenda’s multi-track format is designed to provide comprehensive insights and foster connections between companies…

Continue Reading

ThursdayDec 26, 2024 3:16 pm

NetworkNewsBreaks – IBN to Amplify Reach of Podfest Expo 2025

IBN (“InvestorBrandNetwork”), a pioneer in corporate communications and content distribution, has announced that it was selected as the official media partner for Podfest Expo 2025, hosted by Cutting Edge Events ("CEE"). The expo is slated to take place in-person at the Renaissance Orlando Resort from Jan. 16-19, 2025. As the media sponsor, IBN will leverage its extensive corporate communications capabilities to maximize event visibility across digital platforms. “We’re thrilled to continue our collaboration with Cutting Edge Events and support their efforts to empower the podcasting and creator communities,” said Randy Clark, director of global operations at IBN. “At IBN, we’re…

Continue Reading

ThursdayDec 26, 2024 3:03 pm

NetworkNewsBreaks – Cyngn Inc. (NASDAQ: CYN) Closes $20M Follow-On Offering

Cyngn (NASDAQ:CYN), a developer of AI-powered autonomous driving software solutions for industrial applications, has announced the closing of a follow-on offering, priced at the market, with gross proceeds to the company of approximately $20.0 million. The transaction closed on Dec. 23, 2024. Cyngn intends to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis. To view the full…

Continue Reading

ThursdayDec 26, 2024 2:40 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently received additional written guidance and a roadmap from the U.S. Food and Drug Administration’s (“FDA”) Division of Neurology 1 regarding a potential accelerated approval pathway for lead drug candidate CNM-Au8 in ALS. “The FDA guidance on a potential path to meet the regulatory standard for substantial evidence of effectiveness supporting accelerated approval came following an in-person Nov. 1 Type C meeting with…

Continue Reading